Co-Diagnostics (CODX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Join SI Premium – FREE
Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $0 .
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
